tldrdailynews.com logo
Tag

Glp 1 Drugs

All articles tagged with #glp 1 drugs

GLP-1 Drugs Spark Unexpected Fragrance Obsession
wellness8 days ago

GLP-1 Drugs Spark Unexpected Fragrance Obsession

As GLP-1 medications used for weight loss (e.g., Ozempic, Wegovy, Mounjaro) help quiet food cues, some users report a heightened obsession with fragrances and stronger scent perception. Experts suggest reduced food reward may make non-food senses more salient, potentially involving GLP-1 receptors in the olfactory system; while anecdotes are growing, large controlled studies are still needed. A few FAERS reports mention parosmia, which could also influence fragrance preferences.

via HuffPost|
#fragrance#glp-1-drugs#scent-sensitivity
On Holding tops estimates as premium strategy pays off; Hims & Hers posts surprise loss, shares slide
business14 days ago

On Holding tops estimates as premium strategy pays off; Hims & Hers posts surprise loss, shares slide

On Holding beat Wall Street with $1.07B revenue and $0.40 adjusted EPS for Q1 2026, and lifted profitability targets to at least 64.5% gross margin and 19.5–20% EBITDA margin for 2026. In contrast, Hims & Hers Health swung to a Q1 net loss of $92.1M (−$0.40 per share) on $608M revenue, missing estimates, as it pivots to branded GLP-1 products and partners with Novo Nordisk; the stock fell about 8% after hours amid the weaker results.

via Yahoo Finance Singapore|
#after-hours-reaction#business#earnings
GLP-1 diabetes medicines show potential to curb Alzheimer's protein buildup in preclinical studies
health27 days ago

GLP-1 diabetes medicines show potential to curb Alzheimer's protein buildup in preclinical studies

A new review of mostly preclinical studies links GLP-1 diabetes/weight-loss medications (e.g., semaglutide, liraglutide) to reduced amyloid-beta plaques and tau tangles in cells and animals, with only two small human trials reporting mixed results; still early evidence and larger clinical trials are needed to confirm cognitive benefits.

via ScienceAlert|
#alzheimers-disease#amyloid-beta#clinical-trials
Experts warn: 5 key missteps when using GLP-1 weight-loss drugs
health29 days ago

Experts warn: 5 key missteps when using GLP-1 weight-loss drugs

GLP-1 medications such as semaglutide and tirzepatide can aid weight loss and may improve cardiovascular and kidney health, but misuse can undermine results or cause harm. Doctors warn of five common mistakes: skipping labs or ignoring underlying health issues, poor nutrition or inadequate protein, cutting calories without adequate protein, increasing GLP-1 doses too quickly, and obtaining medications online without medical oversight. For best results, get a medical evaluation with labs first, monitor fat loss versus lean mass monthly, maintain a protein-rich balanced diet with smaller meals, and titrate doses gradually to minimize side effects and risks like pancreatitis.

via AOL.com|
#dosing#glp-1-drugs#health
GLP-1 Weight-Loss Drugs Deliver Big Wins, But With Notable New Risks
health1 month ago

GLP-1 Weight-Loss Drugs Deliver Big Wins, But With Notable New Risks

GLP-1 medications used for obesity and diabetes (e.g., Wegovy, Ozempic, Mounjaro, Zepbound) have driven substantial weight loss and improved health markers, with reports of cardiovascular risk reduction and liver disease improvements; some studies also hint at benefits for fertility, cancer risk, and possibly aging-related conditions, while research continues. However, these drugs can cause drawbacks such as hair thinning, excess skin, muscle and bone loss, gallbladder issues, vision changes, and dental concerns. Experts emphasize slow, steady weight loss, adequate nutrition, and careful monitoring as more long-term effects are studied.

via Sun Sentinel|
#cardiovascular-health#glp-1-drugs#health
Endoscopic gut reset may lock in GLP-1 weight loss after stopping meds
health1 month ago

Endoscopic gut reset may lock in GLP-1 weight loss after stopping meds

A minimally invasive endoscopic procedure called duodenal mucosal resurfacing may help people maintain weight loss after discontinuing GLP-1 diabetes/weight-loss drugs. In a six‑month follow‑up of 45 participants (29 treated, 16 sham) who had at least 15% weight loss on tirzepatide, the procedure group regained about seven pounds and kept over 80% of their drug‑induced weight loss, while the sham group regained more, suggesting a durable metabolic reset observed at Digestive Disease Week 2026.

via AOL.com|
#duodenal-mucosal-resurfacing#glp-1-drugs#health
Reddit AI Scan Flags Potentially Hidden Side Effects in GLP-1 Weight-Loss Drugs
health1 month ago

Reddit AI Scan Flags Potentially Hidden Side Effects in GLP-1 Weight-Loss Drugs

AI analyzed over 400,000 Reddit posts from about 70,000 users over five years to surface patient-reported side effects of GLP-1 medications (including semaglutide and tirzepatide). While many reported issues align with known effects, the study highlights potentially underreported symptoms such as menstrual irregularities and temperature-related changes, suggesting online patient discussions can provide early safety signals. Causation isn’t established, and researchers advocate broader, multilingual follow-up beyond Reddit to validate findings and inform clinicians.

via SciTechDaily|
#drug-safety#glp-1-drugs#health
Body positivity endures as slimming trends rise with GLP-1 era
health1 month ago

Body positivity endures as slimming trends rise with GLP-1 era

A Axios piece argues the body positivity movement remains vital even as a GLP-1–driven slimming trend and celebrity focus dominate media, risking a return to thin-ideal norms. Experts warn this creates a two-tier world where access to medical weight interventions shapes self-perception and mental health, while activists emphasize reframing GLP-1s as disease-treating tools rather than vanity products. The fight for body diversity is framed as a social-justice issue that remains ongoing despite changing trends.

via Axios|
#body-image#body-positivity#glp-1-drugs
Heart protection from GLP-1 drugs fades quickly after stopping, study finds
health2 months ago

Heart protection from GLP-1 drugs fades quickly after stopping, study finds

A Washington University study of more than 333,000 U.S. veterans with type 2 diabetes found that continuous GLP-1 therapy reduced cardiovascular risk by about 18% after three years; stopping the medication for six months raised risk by 4%, after one year by 14%, and after two years by 22%, with restarting yielding only partial protection, highlighting the importance of long‑term use and accompanying lifestyle changes.

via AOL.com|
#bmj-medicine#cardiovascular-risk#glp-1-drugs
GLP-1 Weight-Loss Drugs Reveal Hidden Costs Beyond the Scale
health2 months ago

GLP-1 Weight-Loss Drugs Reveal Hidden Costs Beyond the Scale

A BuzzFeed Health feature examines how GLP-1 weight-loss medications (like Ozempic, Wegovy and Mounjaro) marketed for medical use are being used cosmetically, triggering a viral Reddit thread about a partner whose two-year Ozempic journey left her with a gaunt appearance, muscle loss, debt, and relationship strain. The piece highlights easy access via telehealth, aggressive marketing, and the risk of body dysmorphia or eating disorders when medical safeguards are bypassed. It emphasizes that these drugs are not miracle cures and should be paired with resistance training and adequate protein, while urging professional support for underlying psychological issues and broader societal pressures around body image.

via BuzzFeed|
#body-dysmorphia#glp-1-drugs#health
GLP-1 Medications Tied to Broad Decrease in Addiction Risk Among Veterans
health2 months ago

GLP-1 Medications Tied to Broad Decrease in Addiction Risk Among Veterans

A VA-led cohort study of 606,434 U.S. veterans with type 2 diabetes found that GLP-1 medicines (including Ozempic, Wegovy, Mounjaro, and Zepbound) are associated with a lower risk of developing substance use disorders across alcohol, opioids, nicotine, cocaine, cannabis and other substances—and with fewer hospitalizations, overdoses, and deaths among veterans who already have an addiction. The study also notes a 25% reduction in suicidal ideation. As observational research, it cannot prove causation, and results may reflect greater health engagement; randomized trials are underway, and GLP-1s are not yet approved as addiction treatments.

via Military.com|
#addiction#cohort-study#glp-1-drugs
GLP-1 Weight-Loss Drugs May Shield Heart Microvessels After Heart Attacks
science2 months ago

GLP-1 Weight-Loss Drugs May Shield Heart Microvessels After Heart Attacks

A Bristol/UCL study suggests GLP-1 weight-loss meds like semaglutide and liraglutide may protect heart tissue after a heart attack by relaxing pericytes and widening microvessels to prevent ‘no-reflow’—a finding from animal studies that hints at repurposing these drugs for post-infarct cardioprotection, though human trials are needed.

via SciTechDaily|
#glp-1-drugs#heart-attack#microvasculature